| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.3M | +266.7% |
| R&D Expense | $114.2M | +6.3% |
| SG&A Expense | $32.0M | +5.6% |
| Operating Income | -$135.8M | -0.7% |
| Interest Expense | $2.8M | -24.2% |
| Income Tax | $0 | — |
| Net Income | -$129.8M | -1.8% |
| EPS (Basic) | -$1.00 | +12.3% |
| EPS (Diluted) | -$1.00 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $152.4M | -14.7% |
| Short-term Investments | $111.4M | +0.0% |
| Current Assets | $157.2M | -46.3% |
| Total Assets | $228.8M | -38.4% |
| Current Liabilities | $18.7M | -48.0% |
| Long-term Debt | $32.5M | +1.4% |
| Total Liabilities | $105.7M | -18.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$135.3M | -22.1% |
| Capital Expenditures | $4.4M | +15.2% |
| Investing Cash Flow | $109.4M | +307.9% |
| Financing Cash Flow | -$336K | -100.2% |
| Free Cash Flow | -$139.7M | -21.9% |
| +12.3% |
| Stockholders' Equity |
| $123.1M |
| -48.9% |